Survey of practicing cardiologists in maryland on their choice of thrombolytic therapy for acute myocardial infarction

This publication has 12 references indexed in Scilit:

• A Comparison between Heparin and Low-Dose Aspirin as Adjunctive Therapy with Tissue Plasminogen Activator for Acute Myocardial Infarction
  New England Journal of Medicine, 1990
• In-hospital mortality and clinical course of 20 891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin
  The Lancet, 1990
• Coronary Thrombolysis: Streptokinase or Recombinant Tissue-Type Plasminogen Activator?
  Annals of Internal Medicine, 1990
• Medical costs of coronary artery disease in the United States
  The American Journal of Cardiology, 1990
• TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION
  The Lancet, 1988
• The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial.
  Circulation, 1988
• Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial Infarction
  New England Journal of Medicine, 1987
• Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.
  Circulation, 1987
• A Prospective Randomized Clinical Trial of Intracoronary Streptokinase versus Coronary Angioplasty for Acute Myocardial Infarction
  New England Journal of Medicine, 1986
• RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION
  The Lancet, 1985